AZ9567 is an orally active MAT2a inhibitor with a pIC50 of 9.1. AZ9567 binds to MAT2a allosterically, reduces the synthesis of SAM, decreases SDMA levels, and exerts antiproliferative effects on MTAP-knockout cells. AZ9567 depletes SAM, causes methionine accumulation in plasma and tissues, triggers adaptive disorders in one-carbon metabolism, transsulfuration metabolism and lipid metabolism, and induces oxidative stress, hepatic steatosis and lipid homeostasis imbalance. AZ9567 can be used in studies related to MTAP-deficient/deleted cancers[1][2][3].
Molekulargewicht:
447.44
Reinheit:
99.21
CAS Nummer:
[3056570-19-2]
Formel:
C24H19F2N5O2
Target-Kategorie:
Methionine Adenosyltransferase (MAT)
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten